Retracted: Upregulated immune checkpoint HHLA2 in clear cell renal cell carcinoma: a novel prognostic biomarker and potential therapeutic target

Dongming Chen(Nanjing Medical University), Xianlin Xu(Nanjing Medical University), Yanhao Shen(Nanjing Medical University), Wei Chen(Shanghai Jiao Tong University), Yi Xiao(Nanjing Medical University), Meng Zhu(Nanjing Medical University), Changchun Cao(Fujian Medical University), Yong Xu(Xuzhou Medical College), Shuai Zhu(Nanjing Medical University)
Journal of Medical Genetics
July 2, 2018
10.1136/jmedgenet-2018-105454
Cited by 75

Related Papers

Genetic Risk for Overall Cancer and the Benefit of Adherence to a Healthy Lifestyle
|Cancer Research|2021|121
Link between triglyceride-glucose-body mass index and future stroke risk in middle-aged and elderly chinese: a nationwide prospective cohort study
|Cardiovascular Diabetology|2024|104
Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity
|Science|2024|87
Nonlinear relationship between atherogenic index of plasma and the risk of prediabetes: a retrospective study based on Chinese adults
|Cardiovascular Diabetology|2023|85
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities
|Nature Cancer|2024|85